The Association between C-Reactive Protein and Hypertension of Different United States Participants Categorized by Ethnicity: Applying the National Health and Nutrition Examination Survey from 1999-2010

Objectives: The main objective of this study was to examine the association between the elevated level of C-reactive protein (CRP) and incidence of hypertension before and after adjustments for age, BMI, gender, SES, smoking, diabetes, cholesterol LDL and cholesterol HDL, and to determine whether the association differs by race. Method: Cross sectional data for participants from aged 17 years to 74 years, included in The National Health and Nutrition Examination Survey (NHANES) from 1999 to 2010 were analyzed. The CRP level was classified into three categories (> 3 mg/L, between 1 mg/L and 3 mg/L, and < 3 mg/L). Blood pressure categorization was done using JNC 7 indicator. Hypertension is defined as either systolic blood pressure (SBP) of 140 mmHg or more and diastolic blood pressure (DBP) of 90 mmHg or more, otherwise a self-reported prior diagnosis by a physician. Pre-hypertension was defined as 139 ≥ SBP > 120 or 89 ≥ DBP >80. Multinominal regression model was undertaken to measure the association between CRP level and hypertension. Results: In univariable models, CRP concentrations > 3 mg/L were associated with a 73% greater risk of incident hypertension compared with CRP concentrations < 1 mg/L (Hypertension: odds ratio [OR] = 1.73; 95% confidence interval [CI], 1.50-1.99). Ethnic comparisons showed that American Mexicans had the highest risk of incident hypertension (OR = 2.39; 95% CI, 2.21-2.58). This risk was statistically insignificant after controlling by other variables (Hypertension: OR = 0.75; 95% CI, 0.52-1.08), or categorized by race [American Mexican: OR= 1.58; 95% CI, 0.58-4.26, Other Hispanic: OR = 0.87; 95% CI, 0.19-4.42, Non-Hispanic white: OR = 0.90; 95% CI, 0.50-1.59, Non-Hispanic Black: OR = 0.44; 95% CI, 0.22-0.87. The same results were found for pre-hypertension, and the Non-Hispanic black segment showed the highest significant risk for Pre-Hypertension (OR = 1.60; 95% CI, 1.26-2.03). When CRP concentrations were between 1.0 and 3.0 mg/L in unadjusted models, prehypertension was associated with higher likelihood of elevated CRP (OR = 1.37; 95% CI, 1.15-1.62). The same relationship was maintained in Non-Hispanic white, Non-Hispanic black, and other race (Non-Hispanic white: OR = 1.24; 95% CI, 1.03-1.48, Non-Hispanic black: OR = 1.60; 95% CI, 1.27-2.03, other race: OR = 2.50; 95% CI, 1.32-4.74) while the association was insignificant with American Mexican and other Hispanic. In the adjusted model, the relationship between CRP and prehypertension were no longer available. Contrary, hypertension was not independently associated with elevated CRP, and the results were the same after being grouped by race or adjustments for the possible confounder variables. The same results were obtained when SBP or DBP were on a continuous measure. Conclusions: This study confirmed the existence of an association between hypertension, prehypertension and elevated level of CRP, however this association was no longer available after adjusting by other variables. Ethic group differences were statistically significant at the univariable models, while it disappeared after controlling by other variables. 

Authors:

• Ghada Abo-Zaid

Keywords:

• CRP
• hypertension
• ethnicity
• NHANES
• blood pressure.

References:

[1] Osman R., L'Allier P. l., Elgharib N., & Tardif J. C. (2006). Critical Appraisal of C-Reactive Protein Throughout the Spectrum of Cardiovascular Disease. Vasc Health Risk Manag., 2(3): 221–237.
[2] Blake, G. J., Rifai, N., Buring, J. E., & Ridker, P. M. (2003). Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation, 108(24), 2993-2999.
[3] Hage, F.G. (2013). C-reactive protein and Hypertension. Journal of Human Hypertension 28, 410–415; doi:10.1038/jhh.2013.111
[4] Lakoski, S. G., Cushman, M., Palmas, W., Blumenthal, R., D’Agostino, R. B., & Herrington, D. M. (2005). The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology, 46(10), 1869-1874.
[5] Khera, A., McGuire, D. K., Murphy, S. A., Stanek, H. G., Das, S. R., Vongpatanasin, W., & de Lemos, J. A. (2005). Race and gender differences in C-reactive protein levels. Journal of the American College of Cardiology,46(3), 464-469.
[6] CDC. National Health and Nutrition Examination Survey (NHANES) stored biologic specimens: Guidelines for proposals to use samples and proposed cost schedule. Fed Regist 74(138):35872–5. 2009. Available from: http://www.cdc.gov/ nchs/data/nhanes/Fed_Reg_Serum.
[7] National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) DNA quality control protocol. Hyattsville, MD. 2010. Available from: http://www.cdc.gov/nchs/data/ nhanes/genetics/Quality_Control_ Public.
[8] National Center for Health Statistics. National Health and Nutrition Examination Survey: Plan and Operations, 1999–2010 Available from: http://www.cdc.gov/nchs/data/series/sr_01/sr01_056.pdf
[9] Verdecchia, P., & Angeli, F. (2003). The seventh report of the joint national committee on the prevention, detection, evaluation and treatment of high blood pressure: the weapons are ready. Revista espanola de cardiologia, 56(09), 843-847.
[10] National Center for Health Statistics. National Health and Nutrition Examination Survey 1999–2010 questionnaires, datasets, and related documentation. Hyattsville, MD: Centers for Disease Control and Prevention; 2012. (http://www.cdc.gov/nchs/nhanes.htm). (Accessed June 4, 2012).
[11] Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., ... & Vinicor, F. (2003). Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation, 107(3), 499-511.
[12] Ong KL, Wu BJ, Cheung BM, et al. Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999–2008. Atherosclerosis. 2011;219(2):728–733
[13] National Center for Health Statistics. The National Health and Nutrition Examination Survey 2005–2006. Survey operations manuals, brochures, consent documents. 2009; http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/ current_nhanes_05_06.htm. Accessed June 25, 2011.
[14] National Center for Health Statistics. Laboratory Procedure Manual, Total Cholesterol, Direct HDL, Precipitated HDL, Triglycerides, and LDL, NHANES, (http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l13_c_met_lipids.pdf)
[15] Laaksonen, D. E., Niskanen, L., Nyyssönen, K., Punnonen, K., Tuomainen, T. P., Valkonen, V. P., ... & Salonen, J. T. (2004). C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.Diabetologia, 47(8), 1403-1410
[16] King, D. E., Egan, B. M., Mainous, A. G., & Geesey, M. E. (2004). Elevation of C‐Reactive Protein in People with Prehypertension. The Journal of Clinical Hypertension, 6(10), 562-568.
[17] Bautista, L. E., Lopez-Jaramillo, P., Vera, L. M., Casas, J. P., Otero, A. P., & Guaracao, A. I. (2001). Is C-reactive protein an independent risk factor for essential hypertension?. Journal of hypertension, 19(5), 857-861.
[18] Abramson, J. L., Weintraub, W. S., & Vaccarino, V. (2002). Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension, 39(2), 197-202.
[19] Lakoski, S. G., Cushman, M., Palmas, W., Blumenthal, R., D’Agostino, R. B., & Herrington, D. M. (2005). The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology, 46(10), 1869-1874.
[20] Lakoski, S. G., Herrington, D. M., Siscovick, D. M., & Hulley, S. B. (2006). C-reactive protein concentration and incident hypertension in young adults: the CARDIA study. Archives of internal medicine, 166(3), 345-349.
[21] Franklin, S. S., Pio, J. R., Wong, N. D., Larson, M. G., Leip, E. P., Vasan, R. S., & Levy, D. (2005). Predictors of new-onset diastolic and systolic hypertension The Framingham Heart Study. Circulation, 111(9), 1121-1127.